mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.4 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.4 |